Quadri R, Papotti G M, La Grotta A, Maule S, Zanone M, Valentini M, Fonzo D, Chiandussi L
Cattedra di Medicina Interna, Ospedale San Vito.
Ann Ital Med Int. 1992 Jul-Sep;7(3):148-52.
The influence of the ACE-inhibitors captopril and lisinopril on parasympathetic activity in normotensive subjects was evaluated. Three cardiovascular tests which explored chiefly parasympathetic function (deep breathing, lying to standing and Valsalva test) were performed in 10 normotensive volunteers (mean age 26.1 years) in both basal conditions and after four days of treatment with either captopril (25 mg twice a day) or lisinopril (20 mg once a day). Mean blood pressure was not influenced by captopril, whereas it was significantly lowered with lisinopril (from 94.4 +/- 6.8 to 88.7 +/- 5.7 mmHg; p < 0.05). Neither drug interfered with heart rate or with the results of the deep breathing and Valsalva tests. The 30/15 ratio, an index of heart rate variability during the lying to standing test, significantly worsened after assumption of both captopril (from 1.37 +/- 0.18 to 1.21 +/- 0.14; p < 0.05) and lisinopril (from 1.31 +/- 0.17 to 1.20 +/- 0.11; p < 0.05). Although our subjects had a lisinopril-induced drop in blood pressure, their heart rate remained steady. This finding confirms previous studies reporting the lack of reflex tachycardia during ACE-inhibition. The slight effect of ACE-inhibitors on the results of deep breathing and Valsalva tests suggests that such drugs do not directly stimulate vagal activity; the significant decrease of the 30/15 ratio may be due to a functional impairment of the baroreflex mechanism.
评估了血管紧张素转换酶抑制剂卡托普利和赖诺普利对血压正常受试者副交感神经活动的影响。对10名血压正常的志愿者(平均年龄26.1岁)在基础状态下以及用卡托普利(每日两次,每次25毫克)或赖诺普利(每日一次,每次20毫克)治疗四天后,进行了三项主要探索副交感神经功能的心血管测试(深呼吸、平卧位到站立位以及瓦尔萨尔瓦试验)。卡托普利对平均血压无影响,而赖诺普利使其显著降低(从94.4±6.8降至88.7±5.7毫米汞柱;p<0.05)。两种药物均未干扰心率或深呼吸及瓦尔萨尔瓦试验的结果。30/15比值是平卧位到站立位测试期间心率变异性的一个指标,在服用卡托普利(从1.37±0.18降至1.21±0.14;p<0.05)和赖诺普利(从1.31±0.17降至1.20±0.11;p<0.05)后均显著恶化。尽管我们的受试者因赖诺普利导致血压下降,但其心率保持稳定。这一发现证实了先前关于血管紧张素转换酶抑制期间缺乏反射性心动过速的研究报告。血管紧张素转换酶抑制剂对深呼吸和瓦尔萨尔瓦试验结果的轻微影响表明,此类药物不会直接刺激迷走神经活动;30/15比值的显著降低可能是由于压力反射机制的功能受损。